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In dorsal-ventral (DV) patterning by the TGF-β pathway, an activated receptor complex phosphorylates carboxy-terminal serine residues of the signal transducer Smad1/5/8 (for BMPs) or Smad2/3 (for TGF-β/Activin/Nodal) (Feng & Derynck, 2005; Kishigami & Mishina, 2005; Massagué & Chen, 2000; Moustakas & Heldin, 2009; Muñoz-Sanjuán & H.-Brivanlou, 2001 ). Two of these C-terminally phosphorylated receptor-associated Smads (R-Smads) form a trimer with the Co-Smad (Smad4), and translocate into the nucleus, where they control the expression of their target genes (Chacko et al., 2004; Gaarenstroom & Hill, 2014; Qin, Lam, Correia, & Lin, 2002) . On the ventral side of Xenopus gastrula embryos, high BMP signals upregulate the expression of the BMP downstream genes msx1, dlx3/5 and ap-2, and suppress the expression of the neural marker genes sox2 and ncam, while activating epidermal keratin expression (Feledy et al., 1999; Luo, Matsuo-Takasaki, & Sargent, 2001; Luo, MatsuoTakasaki, Thomas, Weeks, & Sargent, 2002; Pera, Stein, & Kessel, 1999; . As a result, BMP determines ventral fate (nonneural ectoderm).
During formation of the anterior-posterior axis, Wnt signaling is mediated by the Wnt receptor Frizzled, whose activation leads to stabilization of β-Catenin, which is ubiquitinated and degraded via the proteasome through the activity of a destruction complex composed of glycogen synthase kinase-3β (GSK-3β), adenoma polyposis coli (APC), Axin, and the E3-ubiquitin ligase β-TrCP in the absence of ligands (Clevers, 2006; Hikasa & Sokol, 2013; Logan & Nusse, 2004; MacDonald, Tamai, & He, 2009; Nelson & Nusse, 2004; Reya & Clevers, 2005) . Activation of Wnt signals induces the expression of Wnt target genes such as the mid-and hindbrain marker en-2 and the anterior hindbrain marker gbx2 (Li, Kuriyama, Moreno, & Mayor, 2009; McGrew, Takemaru, Bates, & Moon, 1999) . In the FGF pathway, ligand binding to the receptors activates the Ras/ MAPK (mitogen-activated protein kinase) pathway (Li, Wang, Xiao, McKeehan, & Wang, 2016; Pownall & Isaacs, 2010) . Overexpression of FGF4 induces the expression of hoxa7, hoxb9, hoxc6 and several caudal genes that are expressed in the posterior region of embryos, and suppresses anterior development (Isaacs, Pownal, & Slack, 1994; Keenan, Sharrard, & Isaacs, 2006; Northrop & Kimelman, 1994; Pownall, Tucker, Slack, & Isaacs, 1996) .
It has been reported that a gradient of BMP signaling determines the DV axis from anterior to posterior in a time-dependent manner (Tucker, Mintzer, & Mullins, 2008) . Indeed, temporal DV patterning along the AP axis is regulated by AP patterning signals (Wnt, RA, and FGF) in zebrafish (Hashiguchi & Mullins, 2013) . Several factors have been shown to function as potential molecular links that coordinate AP and DV patterning (Braun, Etheridge, Bernard, Robertson, & Roelink, 2003; Cruz et al., 2010; De Robertis, 2008; Fuentealba et al., 2007; Gestri et al., 2005; Lagutin et al., 2003; Niehrs, 2010; Piccolo et al., 1999; Sapkota, Alarcón, Spagnoli, Brivanlou, & Massagué, 2007; Sheng et al., 2010; Takebayashi-Suzuki, Kitayama, TerasakaIioka, Ueno, & Suzuki, 2011) . Regulation of Smads is thought to be a key event that integrates the Wnt, FGF and BMP signaling pathways, and enables embryonic cells to acquire appropriate cell fate along the AP and DV axes. The BMP signal transducer Smad1 is negatively regulated by MAPK and GSK-3β, which phosphorylate residues at the Smad linker region (Gaarenstroom & Hill, 2014; Kuroda, Fuentealba, Ikeda, Reversade, & De Robertis, 2005; Pera, Ikeda, Eivers, & De Robertis, 2003; Sapkota et al., 2007) . After phosphorylation of the linker, the E3 ligases Smad ubiquitination regulatory factor 1 (Smurf1) binds to Smad1 to induce its degradation, and therefore, Wnt and FGF signals regulate BMP signaling positively and negatively, respectively (Fuentealba et al., 2007; Moustakas & Heldin, 2009; Sapkota et al., 2007) . In addition, C-terminally unphosphorylated Mad, a Drosophila homologue of Smad, is required for canonical Wnt signaling through its interaction with the β-Catenin-TCF complex (Eivers, Demagny, Choi, & De Robertis, 2011) . When the BMP signaling is enhanced, unphosphorylated Mad is C-terminally phosphorylated and used for transducing the BMP pathway, thereby suppressing Wnt signaling. Despite these findings, the molecular mechanisms that coordinate formation of the AP and DV axes during early vertebrate development are not fully understood.
The zinc-finger and BTB/POZ (Broad-complex, Tramtrack and Bric-a-brac/Poxvirus and Zinc-finger) domain-containing protein (Zbtb) family is known to regulate the development of lymphocytes, skeletal morphogenesis, fertility, and/or neuronal development (Lee & Maeda, 2012; Siggs & Beutler, 2012) . Some mutant alleles of Zbtb proteins in Drosophila and mouse affect neurological development (Giniger, Tietje, Jan, & Jan, 1994; Hu, Fambrough, Atashi, Goodman, & Crews, 1995; Li et al., 2015; Ryner et al., 1996; Zhu et al., 2006) . Zbtb14 (previously referred to as ZF5, ZNF478 and ZFP161) has been shown to bind to the promoters of c-myc and herpes simplex thymidine kinase genes, and to act as either a transcriptional repressor (Numoto et al., 1993; Yokoro, Yanagidani, Obata, Yamamoto, & Numoto, 1998) or a transcriptional activator (Lee et al., 2004; Numoto, Yokoro, & Koshi, 1999) . Interestingly, human zbtb14 has been mapped to chromosome 18p11.21-pter (Sobek-Klocke et al., 1997) , and is one of the candidate genes for holoprosencephaly type 4 (HPE4), in which congenital malformations of the forebrain and the midface occur (Overhauser et al., 1995) . Although mouse zbtb14 is expressed in various tissues (Numoto et al., 1993) , the biological and physiological roles of Zbtb14 in early vertebrate development remain unclear.
In this study, we identified a Xenopus homologue of zbtb14 as a gene involved in BMP signal inhibition and initially named it BMP inhibitory zinc-finger (biz). We found that Zbtb14 not only induces neural tissue at the expense of epidermis, but also promotes posterior neural development. In addition, Zbtb14 is required for neural development, especially for the formation of posterior neural tissues. Mechanistically, Zbtb14 reduces the level of both phosphorylated and total Smad1/5/8 proteins to inhibit BMP signaling and induces an accumulation of β-Catenin to promote Wnt signaling. Thus, our data suggest that Zbtb14 plays a crucial role in the formation of both DV and AP axes and is involved in a regulatory mechanism that coordinates these patterning events in time and/or space during early development.
| MATERIAL S AND ME THODS

| Cloning of zbtb14 genes and plasmids
As previously reported (Takebayashi-Suzuki, Arita, Murasaki, & Suzuki, 2007) , we performed an expression cloning to identify genes that suppressed BMP signaling after receptor activation and a single positive clone was identified from one positive fraction that remains to be analyzed. Sequence analysis revealed that this positive clone encodes X. laevis L homeologue of zinc finger and BTB domain containing 14 (Zbtb14) (also called zinc finger protein 161 (ZFP161), zinc finger protein 478 (ZNF478) and ZF5 (Numoto et al., 1993) , accession No. NM_001097947). We initially named it BMP inhibitory zinc-finger (Biz/Zbtb14.L); for simplicity, however, we call it Zbtb14 hereafter (Figure 1a The digested fragments were subcloned into pDH105 (a gift from Dr. R. Harland) or pCSf107mT vector (a gift from Dr. M. Taira).
pDH105-zbtb14-GR and pDH105-5′ del-zbtb14 were generated by a PCR-based strategy. The following primer combinations and restriction enzymes were used. pDH105-zbtb14-GR: xlzbtb14-CL5′ pSP6nucβgal (Smith & Harland, 1991) was used for synthesizing β-galactosidase mRNA. Miyazono (University of Tokyo) (Nakao et al., 1997) . To improve the detection of the Flag-tag, 3xFlag-tagged derivatives were generated by a PCR-based strategy and subcloning into pcDNA3 vector as previously described (Takebayashi-Suzuki et al., 2011) . Other expression constructs were provided as follows: pCMV5B-Flag-Smurf1C699A (Addgene plasmid 11753) (Zhu, Kavsak, Abdollah, Wrana, & Thomsen, 1999) , pCMV5B-Flag-Smurf2C716A (Addgene plasmid 11747) (Kavsak et al., 2000) , and Flag-βTrCP (Addgene plasmid 10865) (Zhou, Bogacki, Mcreynolds, & Howley, 2000) . For expression construct of untagged human Zbtb14, pCAG-hzbtb14 was generated by subcloning the BamHI/EcoRI fragment from pDH105-hzbtb14, which was made blunt with T4 DNA polymerase, and ligated into pCAGGS vector. To make expression construct for Myc tagged human Zbtb14, pcDNA3-6XMyc-hzbtb14 was generated by a PCR-based strategy using primers hzbtb14 Eco(U) (5′-GGA ATT CTT CAT CAG TAT GTC TGA AAC C-3′) and hzbtb14 Xba(D) (5′-GCT CTA GAC TAG CTA CAG GCT ATC GTC TC-3′), digested with EcoRI and XbaI and subcloned into Myc-pcDNA3 vector .
| Embryo manipulations, microinjection of antisense morpholino oligonucleotide (MO) and mRNA
Preparation and injection of X. laevis embryos were performed as previously described (Suzuki, Kaneko, Ueno, & Hemmati-Brivanlou, 1997; Takebayashi-Suzuki et al., 2007) . Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop & Faber, 1967) .
Dexamethazone (DEX) treatments were carried out as described previously (Takebayashi-Suzuki et al., 2007) . Antisense morpholino oligonucleotides (MO) and the standard control MO (Cont MO) were obtained from Gene Tools (Philomath, USA). The sequences of the MO against zbtb14.L are as follows: Zbtb14 MOa, 5′-TGT GAA GAT GTC CTT AAG GAA GGC G -3′; 6-mismatched Zbtb14 MOa (6 mis Zbtb14 MOa), 5′-TGT GAA cAT cTg gTT AAG cAA GcC G -3′; Zbtb14 MOb, 5′-GGA AGG CGA AAA AGT AAC TAT CAA G -3′; 6mis Zbtb14 MOb, 5′-GcA Acc CGA AAA AcT AAg TAT gAA G -3′.
The location of these MOs relative to zbtb14.L and zbtb14.S mRNA are shown in Figure S1a . The sequence information for zbtb14.S was obtained from X. laevis genome v9.1 (Xelaev18033616m; chr6S:83960307..83970487). Capped mRNAs were synthesized with a mMESSAGE mMACHINE kit (Life Technologies, USA).
| Semi-quantitative RT-PCR and quantitative-RT-PCR (qPCR)
Capped mRNAs were injected into the animal region of 4-to 8-cell-stage embryos. Ectodermal explants isolated at the blastula stage were subjected to RT-PCR analysis at the indicated stage as described previously (Wilson & Hemmati-Brivanlou, 1995) . 
| Cell culture, transfection, coimmunoprecipitation (co-IP) and immunoblotting (IB)
HeLa cells were maintained in Eagle's minimum essential medium (Nissui, Japan) supplemented with 10% fetal bovine serum (FBS) and L-glutamine (Nakalai tesque, Japan). COS cells were maintained in Dulbecco's modified Eagle's medium (Sigma-Aldrich) supplemented with 10% FBS, penicillin and streptomycin (Nakalai tesque, Japan).
Cells were transfected with expression constructs for Flag-tagged
Smads and/or Myc-tagged hZbtb14 using FuGENE HD and FuGENE6
(Promega, USA) for HeLa and COS cells, respectively, according to the manufacturer's instructions. Empty vector DNA was added in order to keep the total DNA amounts the same per each transfection. To evaluate transfection success, the eGFP/pCS2 (a gift from Dr.
T. Nagai) (Nagai et al., 2002) was co-transfected together. Co-IP and IB were carried out essentially as described previously (Takebayashi- Suzuki et al., 2007 Suzuki et al., , 2011 . When required, the proteasome inhibi- The measurement of cytosolic β-Catenin levels was carried out essentially as described previously (Darken & Wilson, 2001 ). The transfected COS cells were cultured in the presence or absence of 50 mmol/L LiCl for 19 hr and lysed in 1 ml of lysis buffer containing 10 μmol/L MG132 as described above. The cell lysate was incubated with 100 μl of pre-washed concanavalin A (Con A)-Sepharose slurry (Sigma) to remove cadherin-bound β-Catenin at 4°C for 4 hr. Supernatants and Con A-Sepharose were separated by centrifugation, and supernatants were processed for immunoblotting using an anti-β-Catenin antibody (Code 610153; BD Bioscience).
| Lineage tracing and whole-mount in situ hybridization (WISH)
Lineage tracing and whole-mount in situ hybridization were carried out essentially as described previously (Takebayashi-Suzuki et al., 2007 . For morpholino injection, we used fluorescein-tagged
MOs, except for 6-mismatched MO, to identify the injected side of embryos under fluorescence microscope. For probe synthesis, template plasmids, restriction enzymes for linearization, and RNA polymerase for transcription were listed as follows: X. tropicalis zbtb14 (pCSf107mT-xtzbtb14), XhoI, SP6 for sense and EcoRI, T7 for antisense; pax6, BamHI, T7 (Hirsch & Harris, 1997) ; cad2, XhoI, T7 (a gift from Dr. K. Cho) (Pillemer et al., 1998) . For other probes, the synthesis information was described previously (Takebayashi-Suzuki et al., 2007 Yoshida et al., 2016) .
| RE SULTS
| Zbtb14 promotes posterior neural development
To identify a potential gene that regulates BMP signaling during development, we carried out expression cloning in which X. laevis cDNAs were selected on the basis of inhibition of BMP signaling evoked by an activated BMP receptor as previously described (Takebayashi-Suzuki et al., 2007) . This led to the isolation of a X. . Together with β-galactosidase (β-gal) mRNA, zbtb14-GR (125 pg) mRNA was injected unilaterally into both dorsal and ventral animal blastomeres of 8-cell-stage embryos. The injected side of the embryo is indicated by brackets. Expression of sox2, ncam and epidermal keratin analyzed by whole-mount in situ hybridization is shown in purple and β-Gal is stained in red. The top six panels (c-h) show dorsal views with posterior to the top. The bottom panels (i and j) show diagonal views with posterior to the right. (k-r) Zbtb14 expands the expression of the posterior marker cad2 (cdx2) and the spinal cord marker hoxb9 (m and p, respectively; black arrows), and the anterior limits of hoxb9 expression shift anteriorly with respect to the uninjected side of the embryo (r; white arrowheads). By contrast, Zbtb14 severely reduces the expression region of both the fore-and midbrain marker otx2 and the mid-and hindbrain marker en2 on the injected side (k and l, respectively; black arrowheads). Interestingly, the hindbrain marker krox20 shows both reduced and anteriorly shifted expression with respect to the uninjected side of the embryo (black and orange arrowheads in o and n/q, respectively). 
| zbtb14 is expressed in the neural plate and required for the formation of posterior neural tissue and suppression of anterior neural development
Because we found that Zbtb14 promotes neural development in both ectodermal explants and whole embryos, we investigated whether zbtb14 is expressed at the right time and place to perform this function during early development. The temporal expression pattern of zbtb14 was first examined by RT-PCR, and zbtb14 transcripts were detected from the egg (stage 1) throughout X. laevis development (Figure 2a) . In whole-mount in situ hybridization (WISH) analysis of X. laevis embryos, zbtb14 showed faint diffuse expression in the neural plate (data not shown). To investigate the expression pattern of zbtb14 more clearly, we isolated the X. tropicalis orthologue and subsequently performed WISH analysis (use of X. tropicalis gives rise to a better signal-to-noise ratio probably due to its smaller egg size; personal observations).
Zygotic expression of zbtb14 started in the dorsal ectoderm of gastrula embryos (neuroectoderm, Figure 2b (n = 34) and 7% (n = 46), respectively; Figure S1c and d). In addition, the effects mediated by Zbtb14 MOa were reversed by co-injection of 5′ del-zbtb14 mRNA, which has a deletion in the target site of Zbtb14 MOa ( Figure S1 ). Although the majority of zbtb14 morphants show defects, both Zbtb14 MOa and MOb might partially inhibit the zbtb14.S gene, whose sequence was not available at the beginning of this study, because there are some mismatched nucleotides between these MOs and zbtb14.S ( Figure S1a ).
Next, we analyzed the expression of marker genes in neurulastage embryos injected with Zbtb14 MOa in one blastomere at the 2-cell-stage. We found that expression of the late neural marker ncam on the injected side was reduced (28% and 23% of embryos showed severely and weakly reduced expression, respectively; n = 40; Figure 3c and e), and the reduction was reversed by coinjection of 5′ del-zbtb14 mRNA in a dose-dependent manner (17% and 14% of embryos injected with 250 pg of 5′ del-zbtb14 mRNA showed severely and weakly reduced expression, respectively, n = 42; 3% of embryos injected with 500 pg of 5′ del-zbtb14 mRNA showed weakly reduced expression, n = 29; Figure 3d and e). Cont MO (n = 37) and 6mis Zbtb14 MOa (n = 50) showed little or no effect on ncam expression (Figure 3a, b and e) .
Similarly, the neuronal marker n-tubulin was reduced on the injected side (57%, n = 21; Figure 3k ). By contrast, expression of the early neural marker sox2 was not reduced significantly by Zbtb14 knockdown (25%, n = 24; Figure 3g ). In addition, the expression of epidermal keratin was not expanded into the neural plate on the injected side (100%, n = 18; Figure 3m ). These results suggest that Zbtb14 may be dispensable for the early phase of neural induction, and sox2 expression remained after Zbtb14 knockdown might have prevented the expansion of epidermal keratin expression into the neural plate territory. The expression pattern of the paraxial mesodermal marker myod was not significantly affected by either Zbtb14
MOa (100%, n = 24; Figure 3o ) or Zbtb14 MOb (100%, n = 11; data not shown). We found that expression of the spinal cord marker hoxb9 on the injected side was reduced and the anterior limits of hoxb9 expression shifted caudally with respect to the uninjected side of the embryo (77%, n = 31; Figure 3u ). Interestingly, expression of the neural marker pax6 in the trunk was suppressed, and/ or the anterior limits of pax6 expression was shifted caudally, while the anterior expression domain of pax6 was expanded toward the posterior and lateral sides (73%, n = 30; Figure 3q ). Consistent with these data, on the Zbtb14 MOa-injected side, reduction of the hindbrain marker krox20 and expansion of the retinal marker rx2a expression domains were observed concomitantly (48%, n = 46; Figure 3s ).
Similar results were obtained for embryos injected with Zbtb14
MOb (data not shown). Collectively, these results suggest that endogenous Zbtb14 function is required for the formation of posterior neural tissue and suppression of anterior neural development; moreover, Zbtb14 plays an indispensable role in DV and AP patterning of the ectoderm.
| Zbtb14 interacts with and affects signaling components of the BMP and Wnt pathways
Because we identified zbtb14 as a gene that inhibits BMP signaling downstream of the BMP receptor, we investigated the mechanism by which Zbtb14 achieves this inhibition. When analyzed by Expression of sox2 (early neural marker, f and g), ncam (late neural marker, h and i), n-tubulin (differentiated neuronal marker, j and k), epidermal keratin (E. keratin) (epidermal marker, l and m), myod (paraxial mesoderm marker, n and o), pax6 (neural plate and eye field marker, p and q), krox20 (hindbrain marker)/rx2a (eye field marker, r and s), and hoxb9 (spinal cord marker, t and u) genes analyzed by whole-mount in situ hybridization are shown in purple and β-Gal is stained in red. In embryos injected with Zbtb14 MOa, expression of ncam and n-tubulin on the injected side is reduced; however, expression of sox2 is not significantly reduced. The expression pattern of myod is not significantly affected by Zbtb14 MOa. Expression of rx2a on the injected side is expanded, whereas that of krox20 is reduced (s). Expression of hoxb9 is also decreased and shifted posteriorly (horizontal lines mark approximate anterior limits of hoxb9 expression; u). In accordance with these observations, the spinal cord expression of pax6 is suppressed (arrowheads), while the anterior expression domains of pax6 and rx2a are expanded toward the posterior and lateral sides (arrows) (q and s). The injected side of the embryo is indicated by brackets. All panels show dorsal views with posterior to the top, except for pax6 and krox20/rx2a, which show anterior (front) views with dorsal to the top. to degrade Smad3 protein might be explained by the fact that Smurf2, which binds to Zbtb14, can ubiquitinate Smad1 and Smad2, but not Smad3, even though it interacts with Smad1, Smad2 and Smad3 (Lin, Liang, & Feng, 2000; Lönn, Morén, Raja, Dahl, & Moustakas, 2009; Zhang et al., 2001) . Therefore, the specificity of Smad degradation by Zbtb14 might be dependent on its binding partners such as Smurfs. We showed that Zbtb14, which inhibits BMP signaling, is present in the dorsal ectoderm of the early gastrula and neurula (Figure 2 ), and thus is expressed at the right time and place for the formation and patterning of neural tissues.
We found that Zbtb14 is required for expression of the late neural markers ncam and n-tubulin, but not the early neural marker sox2 (Figure 3 ). On the basis of these results, we propose that Zbtb14 is dispensable for neural induction per se, but is required for the differentiation processes of neural development. In this regard, the neural inducing factors (Noggin, Chordin and Follistatin) might be enough (Figure 2i ). Of note, it has been shown that, in Xenopus, inhibition of both BMP and TGF-β/Nodal signaling pathways is required for efficient neural development of the ectoderm (Chang & Harland, 2007) . Therefore, Zbtb14 may contribute to a mechanism that suppresses both BMP and Nodal signaling in the ectoderm to promote the induction of neural tissues.
| Zbtb14 regulates the establishment of the AP axis
In our study, Zbtb14 reduced the protein level of Smad4 and interacted with β-TrCP, which has been shown to polyubiquitinate and degrade both Smad4 and β-Catenin (Figure 4c and g) (Demagny, Araki, & De Robertis, 2014) . Although it is not clear yet how Zbtb14 inhibits BMP signaling while activating the Wnt pathway, it might be involved in a novel regulatory mechanism, in which it interacts with Smurfs, I-Smads and β-TrCP to both stimulate the degradation of Co-Smad/R-Smads and stabilize β-Catenin. suggested that anterior neural tissue is initially induced via inhibition of BMP signaling in an "activation" step, and then "transformed"
by posteriorizing signals such as Wnt and FGF along the AP axis (Nieuwkoop, 1952a,b; Sasai & De Robertis, 1997) . If this is the case, zbtb14 expressed in the anterior region may enhance Wnt signaling only in the presence of Wnt ligands that are normally antagonized by Wnt inhibitors in the anterior part of the embryo. In addition, an alternative but not mutually exclusive possibility is that zbtb14 may function in the differentiation and morphogenetic processes of the eye and brain by regulating both BMP and Wnt pathways locally in the anterior regions.
The BTB/POZ domain located in the N-terminal region of Zbtb14 is an evolutionarily conserved protein-protein interaction motif that is important for homomeric and heteromeric interactions with other BTB/POZ domain proteins (Ahmad, Engel, & Privé, 1998; Bardwell & Treisman, 1994) . In fact, another BTB/POZ domain-containing zinc-finger protein Zbtb21 (also called ZNF295) has been shown to associate directly with Zbtb14 (Wang, Kudoh, Takayanagi, & Shimizu, 2005) . We speculate that Zbtb14 and other factors such as Zbtb21 may function cooperatively to regulate the coordination of AP and DV patterning in early development; this possibility is an interesting topic for further investigation.
Taken together, our results suggest that Xenopus Zbtb14 plays an essential role in the formation of both the DV and the AP axis, and potentially functions as a molecular link that coordinates the formation of these two axes in early development.
